Johnson & Johnson plans next month to disclose average price increases of its prescription drugs, as the industry tries to calm the storm over soaring prices. “We hope that can create a better understanding of the industry and ... ultimately improve patient access to medicines,” Joaquin Duato, head of J&J’s prescription drug business, said Tuesday....